Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for Microbial Load Method Development for Creams – V 2.0

Posted on By

Analytical Method Development: SOP for Microbial Load Method Development for Creams – V 2.0

Standard Operating Procedure for Microbial Load Method Development for Creams in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/260/2025
Supersedes SOP/AMD/260/2022
Page No. Page 1 of 14
Issue Date 21/05/2025
Effective Date 23/05/2025
Review Date 21/05/2026

1. Purpose

To establish a validated procedure for determining microbial load in pharmaceutical cream formulations, including enumeration of total aerobic microbial count (TAMC), total combined

yeasts and molds count (TYMC), and absence of specified pathogens as per pharmacopeial requirements.

2. Scope

This SOP is applicable to the Analytical Method Development (AMD) and Quality Control (QC) departments for evaluating the microbiological quality of cream formulations during development, batch release, and stability studies.

3. Responsibilities

  • Microbiologist: Prepares media, performs microbial enumeration, records and interprets results.
  • QC Analyst: Collects and prepares samples for microbial analysis.
  • QA Executive: Ensures compliance with regulatory standards and approves the test protocol and data.

4. Accountability

The Head of Analytical Method Development is accountable for the suitability and regulatory compliance of the microbial load testing method and its proper validation.

See also  Analytical Method Development: Reagent Qualification for Method Development - V 2.0

5. Procedure

5.1 Sample Collection and Preparation

  1. Use aseptic technique to collect representative samples from at least three points (top, middle, bottom) of the batch container.
  2. Weigh 10 g of cream into a sterile container.
  3. Dilute with 90 mL of sterile diluent (e.g., phosphate buffer pH 7.2 or peptone water).
  4. Homogenize the sample using a vortex mixer or homogenizer for 5 minutes.

5.2 Media and Reagents

  • Plate Count Agar (PCA) for TAMC
  • Sabouraud Dextrose Agar (SDA) for TYMC
  • Bile Salt Agar, MacConkey Agar, Mannitol Salt Agar, and XLD Agar for specified pathogens

5.3 Total Aerobic Microbial Count (TAMC)

  1. Transfer 1 mL of sample dilution (10-1 to 10-3) into sterile Petri dishes.
  2. Pour 15–20 mL of sterile melted PCA and swirl to mix.
  3. Incubate plates at 30–35°C for 3–5 days.
  4. Count colonies and express as CFU/g.

5.4 Total Yeast and Mold Count (TYMC)

  1. Repeat the procedure as above using SDA.
  2. Incubate at 20–25°C for 5–7 days.
  3. Count fungal colonies and express as CFU/g.
See also  Analytical Method Development: SOP for Content Uniformity in Capsules - V 2.0

5.5 Test for Specified Pathogens

  1. Perform tests for Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, and Salmonella spp.
  2. Use selective enrichment broth followed by selective agar plating.
  3. Incubate as per respective pharmacopeial methods and confirm using biochemical identification kits or test strips.

5.6 Acceptance Criteria (As per USP/Ph. Eur.)

  • TAMC: NMT 103 CFU/g
  • TYMC: NMT 102 CFU/g
  • Pathogens: E. coli, S. aureus, P. aeruginosa, Salmonella spp. – Absence in 1 g or 10 g as applicable

5.7 Method Validation Parameters

  1. Recovery Studies: Spike known counts into placebo and test matrix. Recovery between 70–130%.
  2. Specificity: Ability to detect and distinguish organisms in presence of product matrix.
  3. Robustness: Evaluate under varied incubation times and temperatures.

5.8 Documentation

  1. Document results in Microbial Load Test Log (Annexure-1).
  2. Include media preparation, lot numbers, incubation conditions, colony count calculations, and analyst initials.

6. Abbreviations

  • TAMC: Total Aerobic Microbial Count
  • TYMC: Total Yeast and Mold Count
  • CFU: Colony Forming Units
  • USP: United States Pharmacopeia
  • Ph. Eur.: European Pharmacopoeia

7. Documents

  1. Microbial Load Test Log – Annexure-1
  2. Pathogen Detection Record – Annexure-2
  3. Validation Report Summary – Annexure-3
See also  Analytical Method Development: SOP for Accuracy Study Using Recovery Method - V 2.0

8. References

  • USP <61>: Microbial Enumeration Tests
  • USP <62>: Tests for Specified Microorganisms
  • Ph. Eur. 2.6.12 and 2.6.13
  • ICH Q6A: Specifications – Test Procedures and Acceptance Criteria

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Megha Thakur Vivek Chavan Sunita Reddy
Designation Microbiologist QA Reviewer Head – AMD
Department Analytical Method Development QA Analytical Method Development

11. Annexures

Annexure-1: Microbial Load Test Log

Sample ID TAMC (CFU/g) TYMC (CFU/g) Status
CRM-260-01 85 12 Pass

Annexure-2: Pathogen Detection Record

Organism Tested Quantity Result Status
Escherichia coli 1 g Absent Pass
Staphylococcus aureus 1 g Absent Pass

Annexure-3: Validation Report Summary

The microbial load test method for cream formulation CRM-260 was validated with recovery studies showing 92–104%, specificity for all target organisms confirmed, and robustness proven under varying conditions. The method is suitable for routine QC use.

Revision History:

Revision Date Revision No. Details Reason Approved By
21/05/2025 2.0 Updated validation parameters and added Annexure-3 Annual Review Sunita Reddy
15/02/2022 1.0 Initial SOP Release New SOP QA Head
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Quality Assurance: SOP for Approving New Packaging Materials for Injectable Products – V 2.0
Next Post: Failure to Brief Staff on SOPs Ahead of Inspection: A Risk to GMP Audit Readiness

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version